Palmer DH - Search Results

1

Molecularly targeted therapeutics for breast cancer.

Hussain SA, Palmer DH, Spooner D, Rea DW. Hussain SA, et al. Among authors: palmer dh. BioDrugs. 2007;21(4):215-24. doi: 10.2165/00063030-200721040-00002. BioDrugs. 2007. PMID: 17628119 Review.

2

Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.

Chung-Faye G, Palmer D, Anderson D, Clark J, Downes M, Baddeley J, Hussain S, Murray PI, Searle P, Seymour L, Harris PA, Ferry D, Kerr DJ. Chung-Faye G, et al. Clin Cancer Res. 2001 Sep;7(9):2662-8. Clin Cancer Res. 2001. PMID: 11555577 Clinical Trial.

3

Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.

Hussain SA, Palmer DH, Ganesan R, Hiller L, Gregory J, Murray PG, Pastorek J, Young L, James ND. Hussain SA, et al. Among authors: palmer dh. Oncol Rep. 2004 May;11(5):1005-10. Oncol Rep. 2004. PMID: 15069539

4

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.

Hussain SA, Stocken DD, Riley P, Palmer DH, Peake DR, Geh JI, Spooner D, James ND. Hussain SA, et al. Among authors: palmer dh. Br J Cancer. 2004 Aug 31;91(5):844-9. doi: 10.1038/sj.bjc.6602112. Br J Cancer. 2004. PMID: 15292922 Free PMC article. Clinical Trial.

5

CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule.

Palmer DH, Hussain SA, Ganesan R, Cooke PW, Wallace DM, Young LS, James ND. Palmer DH, et al. Oncol Rep. 2004 Oct;12(4):679-82. doi: 10.3892/or.12.4.679. Oncol Rep. 2004. PMID: 15375484

6

Systemic therapies for hepatocellular carcinoma.

Palmer DH, Hussain SA, Johnson PJ. Palmer DH, et al. Expert Opin Investig Drugs. 2004 Dec;13(12):1555-68. doi: 10.1517/13543784.13.12.1555. Expert Opin Investig Drugs. 2004. PMID: 15566313 Review.

7

Endocrine therapy and other targeted therapies for metastatic breast cancer.

Hussain SA, Palmer DH, Moon S, Rea DW. Hussain SA, et al. Among authors: palmer dh. Expert Rev Anticancer Ther. 2004 Dec;4(6):1179-95. doi: 10.1586/14737140.4.6.1179. Expert Rev Anticancer Ther. 2004. PMID: 15606341 Review.

8

Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.

Palmer DH, Chen MJ, Searle PF, Kerr DJ, Young LS. Palmer DH, et al. Gene Ther. 2005 Aug;12(15):1187-97. doi: 10.1038/sj.gt.3302510. Gene Ther. 2005. PMID: 15800660

9

Gene- and immunotherapy for hepatocellular carcinoma.

Palmer DH, Hussain SA, Johnson PJ. Palmer DH, et al. Expert Opin Biol Ther. 2005 Apr;5(4):507-23. doi: 10.1517/14712598.5.4.507. Expert Opin Biol Ther. 2005. PMID: 15934829 Review.

10

Role of chemotherapy in breast cancer.

Hussain SA, Palmer DH, Stevens A, Spooner D, Poole CJ, Rea DW. Hussain SA, et al. Among authors: palmer dh. Expert Rev Anticancer Ther. 2005 Dec;5(6):1095-110. doi: 10.1586/14737140.5.6.1095. Expert Rev Anticancer Ther. 2005. PMID: 16336100 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters